CLINICAL_TRIALS
trial_result
· 2018-12-19
Clinical Trial Update: Long-term Extension Study of BEMA™ Fentanyl [Phase 3]
Summary
Long-term extension study results for BEMA Fentanyl (Phase 3) have been completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioDelivery Sciences International | Conditions: Respiratory Depression | Phase 3 | Status: COMPLETED | Results posted: 2018-12-19